Previous 10 | Next 10 |
SUNNYVALE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it has completed its previously-announced acquisition of Lemonaid Health, Inc. (“Lemonaid Health...
It's tempting to think of all businesses the same way. In reality, companies create all kinds of business models. And different business models are better at creating shareholder value than others. And some business models are really out of the box. For three unique examples, consider ...
Shares of 23andMe (NASDAQ: ME) rose more than 9% on Tuesday. The stock, which closed at $11.36 on Monday, opened at $11.40 and rose as high as $12.44 at midday on Tuesday. The stock has been as low as $7.01 and as high as $18.16 over the past 52 weeks. So far this year, shares are u...
Shares of 23andMe Holding (NASDAQ: ME) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and pharmacy services platform Lemonaid Health (not to be confused with Lemonade (...
Acquisition provides telemedicine platform for 23andMe to advance its vision of individualized primary care that empowers consumers to live healthier lives 23andMe to host investor webcast today at 10:00 AM ET SUNNYVALE, Calif., Oct. 22, 2021 (GLOBE NEWSWIRE) -- 23andMe Hold...
Shares of the genetic-testing company 23andMe (NASDAQ: ME) gained another 16% through Thursday's close this week, according to data from S&P Global Market Intelligence . The biotech's stock is now up by more than 34% over the past two weeks. 23andMe's shares have been ri...
SUNNYVALE, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial results for the fiscal year 2022 second quarter before the market opens on Wednesd...
LumiraDx (NASDAQ:LMDX) +37% after approval for COVID-19 antigen test in India Troika Media (NASDAQ:TRKA) +32%. Puhui Wealth Investment Management (NASDAQ:PHCF) +16%. Valneva (NASDAQ:VALN) +16%. Xiaobai Maimai (NASDAQ:HX) +11%. Cyclerion Therapeutics (NASDAQ:CYCN) +11%. F-star ...
In June, 23andMe (NASDAQ: ME) officially finished the process of going public via a special purpose acquisition company ( SPAC ). These investment vehicles were popular in early 2021, but many have lost value in recent months. This includes 23andMe stock, which currently si...
Stocks extended their recent gains on Friday, with the Dow rising by nearly 400 points. Even on a strong day for the broader averages, cryptocurrency stocks posted standout gains, as another big day for Bitcoin (BTC-USD) gave the sector a lift. Bolstered by the advance in their key underlying...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...